NDC Compounded Drug 70713-103-01 Tetracaine; Benzocaine; Lidocaine
Cream Transdermal
Compounded Drug Product Information
Frequently Asked Questions
What is the NDC number assigned to Benzocaine Lidocaine Tetracaine 20 6 4?
Benzocaine Lidocaine Tetracaine 20 6 4 was assigned by its manufacturer with NDC product code 70713-103. This product is a drug classified as a human compounded drug. Compounded drugs are medications created by combining or altering existing drugs to meet the specific needs of certain patients. The NDC directory only includes information about compounded drugs from facilities that choose to assign NDC numbers to their products.
Which are the NDC package codes for Benzocaine Lidocaine Tetracaine 20 6 4?
The NDC package code 70713-103-01 was assigned to a 120 mL in 1 BOTTLE, PUMP of tetracaine; benzocaine; lidocaine administered transdermal via cream.
Who manufactures this product?
Benzocaine Lidocaine Tetracaine 20 6 4 is manufactured by an outsourced facility and labeled by Wells Pharmacy, Inc. All compounded drugs included in the NDC directory are classified as "Outsourcing Facility Compounded Human Drug Product (Exempt from Approval Requirements)". Outsourcing facilities are a type of drug compounding facility regulated under Section 503B of the FD&C Act could be eligible for exemptions from drug registration if they meet all the conditions specified under Section 503B.